Rapidemic
Pre-clinicalMolecular point-of-care tests for fast and accurate diagnosis of sexually transmitted infections.
Founded
2020
Focus
Diagnostics
About
Molecular point-of-care tests for fast and accurate diagnosis of sexually transmitted infections.
Funding History
2Total raised: $3.5M
Seed$3MUndisclosedAug 15, 2021
Grant$500KEuropean Innovation CouncilMar 15, 2020
Company Info
TypePrivate
Founded2020
LocationAmsterdam, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile